» Articles » PMID: 37425315

Evaluation of Diagnostic Accuracy of Dual-energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension Compared to V/Q-SPECT and Pulmonary Angiogram

Abstract

Purpose: The relevance of dual-energy computed tomography (DECT) for the detection of chronic thromboembolic pulmonary hypertension (CTEPH) still lies behind V/Q-SPECT in current clinical guidelines. Therefore, our study aimed to assess the diagnostic accuracy of DECT compared to V/Q-SPECT with invasive pulmonary angiogram (PA) serving as the reference standard.

Methods: A total of 28 patients (mean age 62.1 years ± 10.6SD; 18 women) with clinically suspected CTEPH were retrospectively included. All patients received DECT with the calculation of iodine maps, V/Q-SPECT, and PA. Results of DECT and V/Q-SPECT were compared, and the percent of agreement, concordance (utilizing Cohen's kappa), and accuracy (kappa) to PA were calculated. Furthermore, radiation doses were analyzed and compared.

Results: In total, 18 patients were diagnosed with CTEPH (mean age 62.4 years ± 11.0SD; 10 women) and 10 patients had other diseases. Compared to PA, accuracy and concordance for DECT were superior to V/Q-SPECT in all patients (88.9% vs. 81.3%; k = 0.764 vs. k = 0.607) and in CTEPH patients (82.4% vs. 70.1%; k = 0.694 vs. k = 0.560). Furthermore, the mean radiation dose was significantly lower for DECT vs. V/Q-SPECT ( = 0.0081).

Conclusion: In our patient cohort, DECT is at least equivalent to V/Q-SPECT in diagnosing CTEPH and has the added advantage of significantly lower radiation doses in combination with simultaneous assessment of lung and heart morphology. Hence, DECT should be the subject of ongoing research, and if our results are further confirmed, it should be implemented in future diagnostic PH algorithms at least on par with V/Q-SPECT.

Citing Articles

Advancements in Machine Learning and Artificial Intelligence in the Radiological Detection of Pulmonary Embolism.

Mohanarajan M, Salunke P, Arif A, Iglesias Gonzalez P, Ospina D, Benavides D Cureus. 2025; 17(1):e78217.

PMID: 40026993 PMC: 11872007. DOI: 10.7759/cureus.78217.


Imaging in chronic thromboembolic pulmonary disease: Current practice and advances.

Ghani H, Weir-McCall J, Ruggiero A, Pepke-Zaba J Int J Cardiol Congenit Heart Dis. 2024; 17:100536.

PMID: 39711768 PMC: 11657945. DOI: 10.1016/j.ijcchd.2024.100536.


Is it Possible to Monitor CTEPH without Ventilation Study?.

Boktor R, Lee S, Bom H Nucl Med Mol Imaging. 2024; 58(7):389-391.

PMID: 39635634 PMC: 11612038. DOI: 10.1007/s13139-024-00867-0.


Pulmonary perfusion in long-term survivors of COVID-19-related severe acute respiratory distress syndrome treated by extracorporeal membrane oxygenation.

Miksova L, Dytrych V, Ptacnik V, Balik M, Linhart A, Belohlavek J Pulm Circ. 2024; 14(3):e12431.

PMID: 39188535 PMC: 11345203. DOI: 10.1002/pul2.12431.


Multimodality imaging of acute and chronic pulmonary thromboembolic disease.

Muscogiuri E, De Wever W, Gopalan D Breathe (Sheff). 2024; 20(1):230130.

PMID: 38482190 PMC: 10928553. DOI: 10.1183/20734735.0130-2023.

References
1.
Wiedenroth C, Rolf A, Steinhaus K, Adameit M, Kriechbaum S, Haas M . Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension. J Heart Lung Transplant. 2022; 42(1):134-139. DOI: 10.1016/j.healun.2022.08.011. View

2.
Dournes G, Verdier D, Montaudon M, Bullier E, Riviere A, Dromer C . Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol. 2013; 24(1):42-51. DOI: 10.1007/s00330-013-2975-y. View

3.
Simonneau G, Gatzoulis M, Adatia I, Celermajer D, Denton C, Ghofrani A . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D34-41. DOI: 10.1016/j.jacc.2013.10.029. View

4.
Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Heart J. 2015; 37(1):67-119. DOI: 10.1093/eurheartj/ehv317. View

5.
Kawakami T, Matsubara H, Shinke T, Abe K, Kohsaka S, Hosokawa K . Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial. Lancet Respir Med. 2022; 10(10):949-960. DOI: 10.1016/S2213-2600(22)00171-0. View